Håkan Rosén
Directeur/Membre du Conseil chez Glucox Biotech AB
Fortune : 704 307 $ au 31/05/2024
Profil
Håkan Rosén is Head of SAAB Ventures and Investment Manager of Iteksa Venture AB.
He is a Director of Micromuscle AB.
He received an MS degree from Linköpings Universitet.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FORTNOX AB
0,02% | 02/05/2024 | 114 205 ( 0,02% ) | 704 307 $ | 31/05/2024 |
Postes actifs de Håkan Rosén
| Sociétés | Poste | Début |
|---|---|---|
Glucox Biotech AB
 Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | - |
Anciens postes connus de Håkan Rosén
| Sociétés | Poste | Fin |
|---|---|---|
Saab Ventures AB
 Saab Ventures AB Investment ManagersFinance Saab Ventures is the venture capital unit of Saab AB (ST: SAAB), which was founded in 1937 as Svenska Aeroplan Aktiebolaget to produce military aircraft for Sweden. Grown into a global group, the firm provides products and services for military defense and civil security. Their corporate venture division Saab Ventures was established in 2001 and is based in Linköping, Sweden. Saab Ventures invests from the balance sheet of Saab and focuses on technologies and markets that are relevant to Saab's short- and long-term strategies. They aim to enhance Saab's access to innovative key technologies. | Directeur en chef des Investissements | 31/12/2008 |
Svenska TRACAB AB
 Svenska TRACAB AB Packaged SoftwareTechnology Services TRACAB is the world leading company in creating real-time digital sports data and in turn converting the data into powerful content products for sports fans. Using patented image processing technology developed by its shareholder SAAB, TRACAB is able to capture all movements in a sports arena in real-time. The captured data is packaged into different media products for different platforms such as broadband, broadcast, print and mobile. It is made available to the consumer both in real-time and in post-production. The technology is well proven and is used by several national football leagues and the UEFA Champions League. It was also used for all matches during the EURO 2008. Since 2004, the TRACAB system has been used in over 1,000 live matches. | Directeur/Membre du Conseil | - |
Micromuscle AB
 Micromuscle AB Medical SpecialtiesHealth Technology Micromuscle AB develops electro-active polymer technology products. It focuses on vascular applications where EAP has considerable potential and enables functionality for medical devices. The company's products are used in medical and life science applications. Micromuscle was founded in 2000 and is headquartered in Linköping, Sweden | Directeur/Membre du Conseil | - |
Iteksa Venture AB
 Iteksa Venture AB Investment ManagersFinance Iteksa Venture AB is engaged in developing the companies in its portfolio and making investments in new companies. It invests primarily in high-tech companies in the Linköping region. The company is headquartered in Linköping, Sweden. | Directeur/Membre du Conseil | - |
Formation de Håkan Rosén
| University of Linköping | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Iteksa Venture AB
Iteksa Venture AB Investment ManagersFinance Iteksa Venture AB is engaged in developing the companies in its portfolio and making investments in new companies. It invests primarily in high-tech companies in the Linköping region. The company is headquartered in Linköping, Sweden. | Finance |
Micromuscle AB
Micromuscle AB Medical SpecialtiesHealth Technology Micromuscle AB develops electro-active polymer technology products. It focuses on vascular applications where EAP has considerable potential and enables functionality for medical devices. The company's products are used in medical and life science applications. Micromuscle was founded in 2000 and is headquartered in Linköping, Sweden | Health Technology |
Saab Ventures AB
Saab Ventures AB Investment ManagersFinance Saab Ventures is the venture capital unit of Saab AB (ST: SAAB), which was founded in 1937 as Svenska Aeroplan Aktiebolaget to produce military aircraft for Sweden. Grown into a global group, the firm provides products and services for military defense and civil security. Their corporate venture division Saab Ventures was established in 2001 and is based in Linköping, Sweden. Saab Ventures invests from the balance sheet of Saab and focuses on technologies and markets that are relevant to Saab's short- and long-term strategies. They aim to enhance Saab's access to innovative key technologies. | Finance |
Svenska TRACAB AB
Svenska TRACAB AB Packaged SoftwareTechnology Services TRACAB is the world leading company in creating real-time digital sports data and in turn converting the data into powerful content products for sports fans. Using patented image processing technology developed by its shareholder SAAB, TRACAB is able to capture all movements in a sports arena in real-time. The captured data is packaged into different media products for different platforms such as broadband, broadcast, print and mobile. It is made available to the consumer both in real-time and in post-production. The technology is well proven and is used by several national football leagues and the UEFA Champions League. It was also used for all matches during the EURO 2008. Since 2004, the TRACAB system has been used in over 1,000 live matches. | Technology Services |
Glucox Biotech AB
Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Health Technology |
